Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey
Yıl: 2021 Cilt: 37 Sayı: 3 Sayfa Aralığı: 222 - 231 Metin Dili: İngilizce DOI: 10.47717/turkjsurg.2021.5069 İndeks Tarihi: 01-06-2022
Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey
Öz: Objective: COVID-19 disease, which rapidly became a pandemic, led to significant changes in the provision of health services. This included radical
changes to the supply and delivery of routine services to release resources for emergency care. During this process, a range of restrictions were imposed
including the recommended rules to be followed before, during and after surgery. Health services provided for breast cancer diagnosis, treatment and
follow-up have also undergone enforced changes meaning the diagnosis, treatment, and follow-up of patients with priority has come to the fore. In this
study, the effect of the COVID-19 pandemic in Turkey, between March 11, 2020 and May 31, 2020 was assessed in comparison to pre-pandemic practice
in terms of divided into two periods, and breast cancer diagnosis, treatment, and follow-up.
Material and Methods: Surgeons dealing with breast cancer treatment and registered to SENATURK (Turkish Senology Academy) were contacted on-
line. The period was divided into two, between March 11th and April 30th and May 1st to May 31st
, 2020. Surgeons were requested to complete two elec-
tronic evaluation forms, one for each period, investigating change in practice. Only complete responses for both periods were included in the analysis.
Results: There were 93 respondents. Except for less multidisciplinary breast councils, there was no delay in radiological and pathological diagnoses. The
number of breast cancer surgeries increased in Period 2, and more COVID-19 positive breast cancer patients were operated in Period 2. Benign breast
patients were delayed less frequently in Period 2. In the statistical analysis performed between the two groups, it was found that only a significant dif-
ference was in the number of outpatients with benign breasts.
Conclusion: With sufficient awareness of the risks of COVID-19 and with individual protection, breast cancer treatment was not affected during the
assessed period of active pandemic in Turkey.
Anahtar Kelime: Türkiye’de COVID-19 pandemisinin yaşandığı iki aktif dönemde, meme kanserinin tanı, tedavi ve takibinde yaşanan değişimler ve aksamalar
Öz: Giriş ve Amaç: Tüm dünyada hızla yayılarak kısa sürede pandemi haline gelen COVID-19 hastalığı sebebiyle her alanda olduğu gibi, özellikle
sağlık alanında da rutinler bozularak, verilen sağlık hizmetlerinde önemli değişiklikler yapılamasına karar verilmiştir. Bu süreçte özellikle mevcut
sağlık kurumlarında verilen rutin sağlık hizmetlerinde COVID-19 ile savaş sebebiyle belirli kısıtlamalara gidilmiştir. Yapılacak cerrahilerin öncesi,
esnası ve sonrası için uyulması önerilen kurallar ortaya koyulmuştur. Meme kanseri tanı, tedavi ve takibi için verilen sağlık hizmetleri de bu sebep-
le belli değişimlere uğramıştır. Önceliği olan hastaların tanı, tedavi ve takibi gündeme gelmiştir. Bu çalışmada Türkiye’de COVID-19’un aktif olarak
yaşandığı 11 Mart 2020 ile 31 Mayıs 2020 arasındaki süreç, 2 döneme ayrılarak, meme kanseri tanı, tedavi ve takibi, hizmet veren cerrahların ve
kurumların etkilenme süreci ile birlikte değerlendirilmiştir.
Gereç ve Yöntem: SENATURK (Türkiye Senoloji Akademisi)’ne kayıtlı, Türkiye’de meme kanseri tedavisi ile uğraşan cerrahlara çevrimiçi yollarla
ulaşılarak elektronik olarak hazırlanan değerlendirme formu iletilmiş ve alınan cevaplar değerlendirilmiştir.
Bulgular: 93 katılımcının verileri değerlendirilmiştir. Multidisipliner meme konseylerinin daha az yapılması dışında, radyolojik ve patolojik tanılar-
da gecikme olmamıştır. 2. dönemde meme kanseri ameliyatı sayısı artmıştır ve ameliyat edilen COVID-19 pozitif meme kanseri hasta sayısı artmış-
tır. 2. dönemde benign meme hastalıkları açısından daha az gecikme kaydedilmiştir. Her iki grupta ayakta tedavi gören benign meme hastalarının
sayısında sadece anlamlı farkın olduğu bulunmuştur.
Sonuç: Cerrahların COVID-19 pandemisi hakkında yeterli bilinçte olması hem kurumsal hem de kişisel önlemler alınmasıyla meme kanseri has-
talarına hizmet açısından COVID-19 pandemisinin 11 Mart 2020 ile 31 Mayıs 2020 arasındaki aktif pandemi döneminde Türkiye’de genel olarak
aksama olmadan hizmet verilmeye çalışıldığı sonucuna varılmıştır.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Kakodkar P, Kaka N, Baig NM. A comprehensive literature review on the clinical presentation, and management of the pandemic Coro- navirus Disease 2019 (COVID-19). Cureus 2020; 12: e7560. [CrossRef]
- 2. Al-Shamsi HO, Alhazzani W, Alhuraji A, Coomes EA, Chemaly RF, Al- muhanna M, et al. A practical approach to the management of can- cer patients during the novel Coronavirus Disease 2019 (COVID-19) pandemic: An International Collaborative Group. Oncologist 2020; 25: e936-e945. [CrossRef]
- 3. Dietz RJ, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 2020; 181: 487-97. [CrossRef]
- 4. Kamer E, Çolak T. What to do when a patient infected with COVID-19 needs an operation: A pre-surgery, peri-surgery and post-surgery gui- de. Turk J Colorectal Dis 2020; 30: 1-8. [CrossRef]
- 5. Finley C, Prashad A, Camuso N, Daly C, Aprikian A, Ball CG, et al. Gui- dance for management of cancer surgery during the COVID-19 pan- demic. Can J Surg 2020; 63: S2-S4. [CrossRef]
- 6. Çakmak GK, Özmen V. Sars-CoV-2 (COVID-19) outbreak and breast can- cer surgery in Turkey. Eur J Breast Health 2020; 16(2): 83-85. [CrossRef] 7. Soran A, Gimbel M, Diego E. Breast cancer diagnosis, treatment and follow-up during COVID-19 pandemic. Eur J Breast Health 2020; 16: 86-8. [CrossRef]
- 8. Coles CE, Aristei C, Bliss J, Boersma L, Brunt AM, Chatterjee S, et al. In- ternational guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol (R Coll Radiol) 2020; 32: 279-81. [CrossRef]
- 9. Braunstein LZ, Gillespie EF, Hong L, Xu A, Bakhoum SF, Cuaron J, et al. Breast radiotherapy under COVID-19 pandemic resource constraints- approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States. Adv Radiat Oncol 2020; 5: 582-8. [CrossRef]
| APA | Güler S, GÜLER Ö, ŞİMŞEK T, CANTÜRK N (2021). Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. , 222 - 231. 10.47717/turkjsurg.2021.5069 |
| Chicago | Güler Sertaç Ata,GÜLER Özlem Özkan,ŞİMŞEK Turgay,CANTÜRK Nuh Zafer Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. (2021): 222 - 231. 10.47717/turkjsurg.2021.5069 |
| MLA | Güler Sertaç Ata,GÜLER Özlem Özkan,ŞİMŞEK Turgay,CANTÜRK Nuh Zafer Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. , 2021, ss.222 - 231. 10.47717/turkjsurg.2021.5069 |
| AMA | Güler S,GÜLER Ö,ŞİMŞEK T,CANTÜRK N Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. . 2021; 222 - 231. 10.47717/turkjsurg.2021.5069 |
| Vancouver | Güler S,GÜLER Ö,ŞİMŞEK T,CANTÜRK N Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. . 2021; 222 - 231. 10.47717/turkjsurg.2021.5069 |
| IEEE | Güler S,GÜLER Ö,ŞİMŞEK T,CANTÜRK N "Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey." , ss.222 - 231, 2021. 10.47717/turkjsurg.2021.5069 |
| ISNAD | Güler, Sertaç Ata vd. "Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey". (2021), 222-231. https://doi.org/10.47717/turkjsurg.2021.5069 |
| APA | Güler S, GÜLER Ö, ŞİMŞEK T, CANTÜRK N (2021). Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. Turkish Journal of Surgery, 37(3), 222 - 231. 10.47717/turkjsurg.2021.5069 |
| Chicago | Güler Sertaç Ata,GÜLER Özlem Özkan,ŞİMŞEK Turgay,CANTÜRK Nuh Zafer Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. Turkish Journal of Surgery 37, no.3 (2021): 222 - 231. 10.47717/turkjsurg.2021.5069 |
| MLA | Güler Sertaç Ata,GÜLER Özlem Özkan,ŞİMŞEK Turgay,CANTÜRK Nuh Zafer Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. Turkish Journal of Surgery, vol.37, no.3, 2021, ss.222 - 231. 10.47717/turkjsurg.2021.5069 |
| AMA | Güler S,GÜLER Ö,ŞİMŞEK T,CANTÜRK N Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. Turkish Journal of Surgery. 2021; 37(3): 222 - 231. 10.47717/turkjsurg.2021.5069 |
| Vancouver | Güler S,GÜLER Ö,ŞİMŞEK T,CANTÜRK N Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey. Turkish Journal of Surgery. 2021; 37(3): 222 - 231. 10.47717/turkjsurg.2021.5069 |
| IEEE | Güler S,GÜLER Ö,ŞİMŞEK T,CANTÜRK N "Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey." Turkish Journal of Surgery, 37, ss.222 - 231, 2021. 10.47717/turkjsurg.2021.5069 |
| ISNAD | Güler, Sertaç Ata vd. "Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey". Turkish Journal of Surgery 37/3 (2021), 222-231. https://doi.org/10.47717/turkjsurg.2021.5069 |
